trending Market Intelligence /marketintelligence/en/news-insights/trending/O5Oeeu5a2ddJBMiqScg28Q2 content esgSubNav
In This List

HRA Capital to help raise funds for Nascent Biotech's brain cancer drug

Blog

Commercial Banking: June 22nd Edition

Blog

Understanding Loss Given Default A Review of Three Approaches

Blog

Commercial Banking Newsletter June Edition - 2022

Blog

Insight Weekly: US recession outlook; mortgage activity slowdown; climate disclosure push


HRA Capital to help raise funds for Nascent Biotech's brain cancer drug

Nascent Biotech Inc. has engaged HRA Capital to help raise capital to fund the continual development of Pritumumab, a drug to treat brain cancer, through its phase 1 and phase 2 clinical trials.